Back
Shanghai Pharmaceuticals Holding Co., Ltd. 10K Form
Sell
47
SHPMF
Shanghai Pharmaceuticals Holding Co., Ltd.
Last Price:
$1.53
Seasonality Move:
0.94%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SHPMF News And Ratings
See the #1 stock for the next 7 days that we like better than SHPMF
SHPMF Financial Statistics
Sales & Book Value
| Annual Sales: | $38.2B |
|---|---|
| Cash Flow: | $149.6M |
| Price / Cash Flow: | 10.31 |
| Annual Sales: | $2.87 |
| Price / Book: | 0.53 |
Profitability
| EPS (TTM): | 0.21050 |
|---|---|
| Net Income (TTM): | $945.5M |
| Gross Margin: | $4B |
| Return on Equity: | 7.87% |
| Return on Assets: | 2.95% |
Shanghai Pharmaceuticals Holding Co., Ltd. Earnings Forecast
Key Shanghai Pharmaceuticals Holding Co., Ltd. Financial Ratios
-
The Gross Profit Margin over the past 32 years for SHPMF is 10.35%.
-
The Selling, General & Administrative Expenses for SHPMF have been equal to 6.70% of Gross Profit Margin.
-
The Research & Development expenses have been 0.79% of Revenue.
-
The Interest Expense is 33.79% of Operating Income.
-
The Net Earning history of SHPMF is 2.14% of Total Revenues.
-
Per Share Earnings over the last 31 years have been positive in 16 years.
Shanghai Pharmaceuticals Holding Co., Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | SHPMF |
| Website: | sphchina.com |
Debt
| Debt-to-Equity Ratio: | 0.81 |
|---|---|
| Current Ratio: | 1.32 |
| Quick Ratio: | 0.98 |
Price-to-Earnings
| Trailing P/E Ratio: | 8.96 |
|---|---|
| Forward P/E Ratio: | 0 |
SHPMF Technical Analysis vs Fundamental Analysis
Sell
47
Shanghai Pharmaceuticals Holding Co., Ltd. (SHPMF)
is a Sell
Is Shanghai Pharmaceuticals Holding Co., Ltd. a Buy or a Sell?
-
Shanghai Pharmaceuticals Holding Co., Ltd. stock is rated a SellThe current Shanghai Pharmaceuticals Holding Co., Ltd. [SHPMF] share price is $1.53. The Score for SHPMF is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.